Gupta, A.; Al-Aubaidy, H.A.; Narkowicz, C.K.; Jelinek, H.F.; Nichols, D.S.; Burgess, J.R.; Jacobson, G.A.
Analysis of Citrus Bioflavonoid Content and Dipeptidyl Peptidase-4 Inhibitory Potential of Commercially Available Supplements. Molecules 2022, 27, 4741.
https://doi.org/10.3390/molecules27154741
AMA Style
Gupta A, Al-Aubaidy HA, Narkowicz CK, Jelinek HF, Nichols DS, Burgess JR, Jacobson GA.
Analysis of Citrus Bioflavonoid Content and Dipeptidyl Peptidase-4 Inhibitory Potential of Commercially Available Supplements. Molecules. 2022; 27(15):4741.
https://doi.org/10.3390/molecules27154741
Chicago/Turabian Style
Gupta, Ankit, Hayder A. Al-Aubaidy, Christian K. Narkowicz, Herbert F. Jelinek, David S. Nichols, John R. Burgess, and Glenn A. Jacobson.
2022. "Analysis of Citrus Bioflavonoid Content and Dipeptidyl Peptidase-4 Inhibitory Potential of Commercially Available Supplements" Molecules 27, no. 15: 4741.
https://doi.org/10.3390/molecules27154741
APA Style
Gupta, A., Al-Aubaidy, H. A., Narkowicz, C. K., Jelinek, H. F., Nichols, D. S., Burgess, J. R., & Jacobson, G. A.
(2022). Analysis of Citrus Bioflavonoid Content and Dipeptidyl Peptidase-4 Inhibitory Potential of Commercially Available Supplements. Molecules, 27(15), 4741.
https://doi.org/10.3390/molecules27154741
